Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine versus citalopram for SSRI-associated sexual dysfunction in women with depression
ACTRN12614000869673Phase 4Completed
- Sponsor
- Mohammad Abbasinazari
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in major depressive disorder (MDD) comparing Fluoxetine group with Citalopram group (2 arms). Primary endpoint: Sexual dysfunction assessed by Female Sexual Function Index. Started Feb 2013; status: completed.
02
Drugs
fluoxetinecitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ACTRN12614000869673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000869673.